-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia
(2046) Views (362) Full article downloads
Authors: W Dale Horst, Michael W Klein, Denise Williams, Steven F Werder
Published Date February 2005
Volume 2005:1(4) Pages 349 - 355
DOI: http://dx.doi.org/10.2147/NDT.S
W Dale Horst, Michael W Klein, Denise Williams, Steven F Werder
Via Christi Research Inc, Wichita, KS, USA
Abstract: This study was designed to determine the feasibility and efficacy of long-term nicotine replacement therapy (NRT) in helping persons with schizophrenia remain tobaccofree. Fifty smokers with a diagnosis of schizophrenia or schizo-affective disorder and whose symptoms had been stable for at least two months were enrolled in a program providing group support and NRT (patches) in individually adjusted doses set to maintain baseline nicotine intake. All participants attended weekly group support/motivation sessions. Smoking activity was determined by measuring carbon monoxide levels in expired air. Participants who quit tobacco use completely during the first three months were entered into a single-blind phase in which they received either placebo or active nicotine patches for up to six additional months, along with biweekly group sessions. Sixty days into the open-label phase, 66% of the subjects had reduced their use of tobacco by at least 75%. After 90 days of open-label treatment, 18 subjects (36%) were tobacco-free and qualified to enter the six-month, single-blind phase, eight on placebo and nine on active patches. A significantly greater proportion of those on placebo (8 of 8) compared with those on active patches (3 of 9) relapsed prior to completion of the 6-month period. This difference is statistically significant at the p = 0.009 level. The results of this study indicate that long-term use of NRT is feasible and effective for sustained tobacco-free success and may be an important strategy for reducing health risks due to tobacco use in this special population.
Keywords: schizophrenia, smoking cessation, nicotine replacement
Readers of this article also read:
The history of barbiturates a century after their clinical introduction
Duration of untreated illness in panic disorder: a poor outcome risk factor?
Opinion - Fluvoxamine
Editorial: Neurology and psychiatry: “Oh, East is East and West is West …” || FREE PAPER ||
Diagnosis and management of osteoporosis in the older senior
Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD
Care of elderly people by the general practitioner and the geriatrician in Belgium: a qualitative study of their relationship
Myocardial infarction in patients over 90 years of age
Hypothyroidism in the elderly: diagnosis and management
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Moderate alcohol consumption and cognitive risk
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference




